Gargano, Nicola <br/><br/>
Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  01 2018 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00596-17  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Africa<br/>Antimalarials--adverse effects<br/>Artemisinins--adverse effects<br/>Drug Combinations<br/>Female<br/>Humans<br/>Infant<br/>Kaplan-Meier Estimate<br/>Malaria, Falciparum--drug therapy<br/>Male<br/>Quinolines--adverse effects<br/>Treatment Outcome